Rapid diagnostic assays for self-monitoring of acute or rebound HIV-1 infection
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93024C00029
- Awardee
-
Darwin Biosciences, Inc. UEI E9NXBCYHTJ14
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,408
Award facts
- Opportunity
-
- SBIRPHS20241 Solicitation number
- Contract value 100% obligated
- $299,408.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Boulder, CO 80301, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Terminate for Convenience | $0 | |
| Original award | $299,408 |
About this award
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Darwin Biosciences, Inc., a minority-owned, woman-owned small business based in Broomfield, Colorado. The $299,408 firm-fixed-price contract is for the development of rapid diagnostic assays to aid in the self-monitoring of acute or rebound HIV-1 infection. The contract has an ultimate completion date of April 14, 2025. As an SBIR Phase I award, this contract is intended to support the early-stage research and development of innovative technologies to address a specific challenge identified by NIAID.
Quick answers
Who was awarded contract 75N93024C00029?
75N93024C00029 was awarded to Darwin Biosciences, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2024.
How much is contract 75N93024C00029 worth?
The government has obligated $299,408 on 75N93024C00029.
Was contract 75N93024C00029 competed?
The extent of competition for 75N93024C00029 was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award